Predictions
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€3.44
08.09.21
08.09.21
-
08.09.22
08.09.22
-34.88%
08.12.21
08.12.21
Could be worthwhile Investment >10% per year
MacroGenics Inc.
Start price
Target price
Perf. (%)
€17.00
07.09.21
07.09.21
€15.00
31.12.23
31.12.23
14.50%
09.09.21
09.09.21
Could be very worthwhile Investment >20% year
Ziopharm Oncology
Start price
Target price
Perf. (%)
€1.99
07.09.21
07.09.21
€4.00
31.12.23
31.12.23
52.84%
01.09.22
01.09.22
Could be worthwhile Investment >10% per year
Poxel S.A.
Start price
Target price
Perf. (%)
€6.46
06.09.21
06.09.21
€5.00
06.09.22
06.09.22
-9.30%
07.10.21
07.10.21
Could be worthwhile Investment >10% per year
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€55.00
06.09.21
06.09.21
€120.00
31.12.23
31.12.23
-43.27%
10.09.21
10.09.21
Could be very worthwhile Investment >20% year
Editas Medicine Inc
Start price
Target price
Perf. (%)
€58.60
05.09.21
05.09.21
€70.00
05.09.22
05.09.22
-8.43%
18.09.21
18.09.21
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Good rating
Very low/no dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€212.55
05.09.21
05.09.21
€333.00
05.09.22
05.09.22
-85.70%
06.09.22
06.09.22
Top 10 in its market
Could be worthwhile Investment >10% per year
Leading role in innovation
Very Future proof/growth oriented business model
Innate Pharma
Start price
Target price
Perf. (%)
€4.80
05.09.21
05.09.21
-
05.09.22
05.09.22
-47.79%
07.03.22
07.03.22
Probably not worthwhile Investment
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€4.42
04.09.21
04.09.21
€2.00
04.09.22
04.09.22
-33.48%
18.09.21
18.09.21
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
Innate Pharma
Start price
Target price
Perf. (%)
€6.20
03.09.21
03.09.21
-
03.09.22
03.09.22
-25.29%
06.09.21
06.09.21
Risky Investment
Valneva SE
Start price
Target price
Perf. (%)
€20.18
03.09.21
03.09.21
€30.00
03.09.22
03.09.22
-59.38%
03.09.22
03.09.22
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Some uniques
Higher risks for its business
Novavax Inc.
Start price
Target price
Perf. (%)
€202.35
31.08.21
31.08.21
€350.00
31.12.23
31.12.23
-85.81%
07.09.22
07.09.22
Could be worthwhile Investment >10% per year
MorphoSys AG
Start price
Target price
Perf. (%)
€47.81
30.08.21
30.08.21
€53.00
30.08.22
30.08.22
5.67%
04.09.21
04.09.21
Could be worthwhile Investment >10% per year
Innovative
Top 10 in its market
Higher risks for its business
MorphoSys AG
Start price
Target price
Perf. (%)
€47.81
30.08.21
30.08.21
€53.00
30.08.22
30.08.22
5.67%
04.09.21
04.09.21
Could be worthwhile Investment >10% per year
Innovative
Top 10 in its market
Higher risks for its business
MacroGenics Inc.
Start price
Target price
Perf. (%)
€20.41
30.08.21
30.08.21
€40.00
31.12.23
31.12.23
-16.71%
07.09.21
07.09.21
Could be very worthwhile Investment >20% year
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€5.65
30.08.21
30.08.21
€12.00
31.12.23
31.12.23
-66.02%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Horizon Pharma plc
Start price
Target price
Perf. (%)
€92.84
30.08.21
30.08.21
€200.00
31.12.23
31.12.23
8.36%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€28.20
30.08.21
30.08.21
€50.00
31.12.23
31.12.23
63.83%
28.06.22
28.06.22
Could be very worthwhile Investment >20% year
Curis Inc.
Start price
Target price
Perf. (%)
€7.08
30.08.21
30.08.21
€30.00
31.12.23
31.12.23
-89.90%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Celldex Therapeutics
Start price
Target price
Perf. (%)
€43.66
30.08.21
30.08.21
€110.00
31.12.23
31.12.23
-31.75%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year